Curis Inc
CRIS Real Time Price USDRecent trades of CRIS by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by CRIS's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
-
$15,000 Jan 18, 2018 Issue: Economics/Economic Development
-
$10,000 Jul 16, 2017 Issue: Economics/Economic Development
-
$10,000 Apr 18, 2017 Issue: Economics/Economic Development
-
$10,000 Jan 19, 2017 Issue: Economics/Economic Development
-
$10,000 Oct 16, 2016 Issue: Economics/Economic Development
-
$10,000 Jul 17, 2016 Issue: Economics/Economic Development
-
$10,000 Apr 19, 2016 Issue: Economics/Economic Development
-
$10,000 Jan 17, 2016 Issue: Economics/Economic Development
-
$10,000 Oct 18, 2015 Issue: Economics/Economic Development
-
$10,000 Apr 19, 2015 Issue: Economics/Economic Development
-
$10,000 Jan 19, 2015 Issue: Economics/Economic Development
-
$10,000 Oct 11, 2014 Issue: Indian/Native American Affairs
Estimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Conjoint therapies for immunomodulation Aug. 20, 2024
-
Patent Title: Crystal forms of immunomodulators Mar. 26, 2024
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety May. 23, 2023
-
Patent Title: Crystal forms of immunomodulators May. 09, 2023
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Mar. 07, 2023
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Mar. 01, 2022
-
Patent Title: Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety Feb. 01, 2022
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Oct. 05, 2021
-
Patent Title: Crystal forms of immunomodulators Jun. 22, 2021
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jan. 19, 2021
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Nov. 24, 2020
-
Patent Title: Compounds and compositions for treating hematological disorders Sep. 01, 2020
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jun. 09, 2020
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Jan. 28, 2020
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Oct. 01, 2019
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jul. 02, 2019
-
Patent Title: Hedgehog antagonists having zinc binding moieties Feb. 26, 2019
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Oct. 30, 2018
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Jul. 31, 2018
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Aug. 08, 2017
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety May. 23, 2017
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Apr. 25, 2017
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Aug. 02, 2016
-
Patent Title: Pyridyl inhibitors of hedgehog signalling Apr. 26, 2016
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Feb. 02, 2016
-
Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Nov. 03, 2015
-
Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Oct. 27, 2015
-
Patent Title: Crystalline forms of fused amino pyridines as hsp90 inhibitors Oct. 06, 2015
-
Patent Title: Quinazoline based egfr inhibitors Aug. 18, 2015
-
Patent Title: Fused amino pyridine as hsp90 inhibitors May. 26, 2015
-
Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety May. 05, 2015
-
Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Mar. 10, 2015
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Dec. 09, 2014
-
Patent Title: Small organic molecule regulators of cell proliferation Oct. 07, 2014
-
Patent Title: Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety Sep. 30, 2014
-
Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related hereto Aug. 26, 2014
-
Patent Title: Rna interference modulators of hedgehog signaling and uses thereof Aug. 12, 2014
-
Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Jul. 08, 2014
-
Patent Title: Fused amino pyridines for the treatment of brain tumors May. 13, 2014
-
Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Apr. 29, 2014
-
Patent Title: Cdk inhibitors Apr. 08, 2014
-
Patent Title: Variant hhip1 protein and methods and uses thereof Jan. 07, 2014
-
Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Dec. 10, 2013
-
Patent Title: Fused amino pyridine as hsp90 inhibitors Nov. 19, 2013
-
Patent Title: Cdk inhibitors containing a zinc binding moiety Oct. 22, 2013
-
Patent Title: Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety Aug. 27, 2013
-
Patent Title: Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling Jul. 16, 2013
-
Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jun. 11, 2013
-
Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Jun. 04, 2013
-
Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Apr. 23, 2013
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of CRIS in WallStreetBets Daily Discussion
Recent insights relating to CRIS
Recent picks made for CRIS stock on CNBC
ETFs with the largest estimated holdings in CRIS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CRIS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.